Russell Skibsted, Chief Financial Officer at AEOLUS PHARMACEUTICALS, INC. (AOLS), bought 20,000 shares at $0.43 ($8K) on 2011-05-18, disclosed to the SEC on 2011-05-19.
Open-market purchase of $8k AOLS by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.41 | 5,000 | $2K | 24.3% |
| 2 | $0.42 | 5,000 | $2K | 24.9% |
| 3 | $0.43 | 10,000 | $4K | 50.9% |
| Total | $0.42 avg | 20,000 | $8K | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $6K | — | Filing → |